Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free
Category
Global or ExUS Equities - Industry Sector
Sponsor
Global X
Fund Family
Index
Solactive Genomics Index
Index Weighting
Active/Passive
Expense
0.50%
Inverse/Leveraged
IPO
Apr 10, 2019
Asset Type
Equities (Stocks)
ETF Type
Bond Type
Average Maturity
Commodity Type
Quant Type
ESG Type
Dividend Type
Structure Type
Growth/Value
Market Cap
Option/Short
Yes / Yes
Tags
Tags
Tags
Tags
Tags
Tags
-
Tags
-
Sector/Theme
Region
SMA20
8.07%
SMA50
14.74%
SMA200
40.54%
Return% 1Y
77.01%
Return% 3Y
19.97%
Return% 5Y
-5.45%
Return% 10Y
Return% SI
Flows% 1M
2.91%
Flows% 3M
-2.26%
Flows% YTD
21.88%
Flows% 1Y
Flows% 3Y
Flows% 5Y
Trades
Total Holdings
52
AUM
102.59M
NAV/sh
52W High
72.44 0.77%
52W Low
40.17 81.73%
Volatility
2.37% 2.24%
ATR (14)
1.64
RSI (14)
70.42
Beta
1.23
Rel Volume
0.02
Avg Volume
30.04K
Volume
31
Perf Week
3.76%
Perf Month
13.60%
Perf Quarter
27.30%
Perf Half Y
65.89%
Perf YTD
60.59%
Perf Year
77.76%
Perf 3Y
83.79%
Perf 5Y
-14.72%
Perf 10Y
-
Prev Close
72.30
Price
73.00
Change %
0.97%
Jun-20-25 11:56AM
11:56AM
May-02-25 03:25AM
Apr-30-25 04:35AM
Apr-24-25 07:14AM
07:14AM Loading…
07:14AM
Apr-23-25 05:45AM
Apr-20-25 11:28AM
Apr-18-25 01:40PM
Apr-04-25 08:30AM
Apr-02-25 07:00AM
Apr-01-25 05:40AM
Mar-28-25 06:05AM
Mar-20-25 04:32PM
Mar-19-25 03:52PM
01:38PM Loading…
Jan-26-22 01:38PM
Jan-20-22 09:38AM
Jan-13-22 01:38PM
Nov-25-20 03:37PM
Aug-27-20 05:31PM
Jun-08-20 04:00AM
Jun-04-20 12:20PM
May-26-20 12:50PM
07:40AM
Jan-09-20 11:13AM
Dec-26-19 02:30PM
Dec-18-19 01:41PM
Dec-12-19 08:00AM
Dec-04-19 10:23PM
Nov-29-19 12:15PM
06:55PM Loading…
Nov-25-19 06:55PM
Nov-21-19 12:15PM
Oct-30-19 10:43AM
Oct-10-19 09:25AM
Sep-06-19 03:07PM
11:09AM
Sep-04-19 03:18PM
Aug-05-19 12:00PM
Aug-01-19 12:10PM
Jun-24-19 12:17PM
Jun-19-19 11:15AM
Apr-15-19 02:00PM
Apr-11-19 02:18PM
Apr-10-19 08:01AM
Apr-09-19 05:15PM
10:03AM
Global X Genomics & Biotechnology ETF seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Solactive Genomics Index ("underlying index"). The fund invests at least 80% of its total assets in the securities of the underlying index. The underlying index is designed to provide exposure to exchange-listed companies that are positioned to benefit from further advances in the field of genomic science and biotechnology, as well as applications thereof (collectively, "Genomics & Biotechnology Companies"), as defined by Solactive AG, the provider of the underlying index. The fund is non-diversified.